Viewing StudyNCT02473497



Ignite Creation Date: 2024-05-06 @ 7:08 AM
Last Modification Date: 2024-10-26 @ 11:45 AM
Study NCT ID: NCT02473497
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2024-06-26
First Post: 2015-06-12

Brief Title: Crizotinib Xalkori Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Neoplasm
Keywords:
Name View
chromosomal rearrangement View
activating mutation View
activating genetic alteration View
genetic aberration View
ALK View
ROS1 View
cMET View
crizotinib View
oral formulation View